Search Results - "E A Saginova"

Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity by Galiamov, M G, Saginova, E A, Severova, M M, Samokhodskaia, L M, Krasnova, T N, Sholomova, V I, Sorokin, Iu D, Mukhin, N A

“…To define the clinical significance of asymmetric dimethylarginine (ADMA) and that of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism as factors…”
Get full text

The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients by Saginova, E A, Galliamov, M G, Severova, M M, Surkova, O A, Fomin, V V, Ermakov, N V, Rodina, A V, Mukhin, N A

“…To characterize clinicopathogenetically factors influencing development of early chronic kidney disease (CKD) and impairment of other target organs in obese…”
Get full text

CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER by M M Severova, E A Saginova, M G Gallyamov, N V Ermakov, A V Rodina, V V Fomin, N A Mukhin

“…To study clinicopathogenetic characteristics of cardiorenal syndrome (CRS) in non-alcoholic fatty disease of the liver (nAFDL). Material and methods. Insulin…”
Get full text

REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE AND MTHFR by E A Saginova, M G Gallyamov, A V Balatsky, A V Kolotvin, M V Severova, L M Samokhodskaya, V V Fomin, T N Krasnova, N A Mukhin

“…Aim. To examine contribution of polymorphisms of genes of endothelial NO-synthase (eNOS), NADPH-oxidase and methylenetetrahydrofolate reductase (mTHFR) to…”
Get full text

Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome by M M Severova, V V Fomin, M V Lebedeva, Yu D Sorokin, E A Saginova, E G Minakova, M G Gallyamov, N A Mukhin

“…Aim: to assess a relationship between obstructive sleep apnea syndrome (OSAS) and the signs of non-alcoholic fatty liver disease (NAFLD) in patients with…”
Get full text

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? by V. V. Fomin, S. V. Moiseev, E. A. Saginova

“…Angiotensin II receptor blockers are antihypertensive medications demonstrating some benefits in the treatment of high-risk arterial hypertension (AH)…”
Get full text

Development of renal affection in obese patients by Saginova, E A, Fedorova, E Iu, Fomin, V V, Moiseev, S V, Minakova, E G, Gitel', E P, Samokhodskaia, L M, Kutyrina, I M, Mukhin, N A

“…To characterize mechanisms, early markers and clinical signs of renal damage in obesity. The trial covered 29 males aged under 50 years (mean age 37.7+/-9.3…”
Get more information

The clinical significance of adiponectimics in formation of affected target-organs during the metabolic syndrome associated with nonalcoholic fatty liver disease by E. A. Saginova, M. M. Severova, M. G. Gallyamov, N. V. Ermakov, A. V. Rodina, V. V. Fomin, N. A. Mukhin

“…The goal of this research is to estimate the clinical significance of adiponectimics in formation of affected target-organs during the metabolic syndrome…”
Get full text

Renal affection in obesity by Saginova, E A, Fomin, V V, Moiseev, S V, Lebedeva, M V

Get more information

Remodeling of the cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of eNOS, subunit p22-phox of NADPH-oxidase and MTHFR genes by Saginova, E A, Galliamov, M G, Balatskiĭ, A V, Kolotvin, A V, Severova, M V, Samokhodskaia, L M, Fomin, V V, Krasnova, T N, Mukhin, N A

“…To examine contribution of polymorphisms of genes of endothelial NO-synthase (eNOS), NADPH-oxidase and methylenetetrahydrofolate reductase (mTHFR) to…”
Get more information

Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease by Severova, M M, Saginova, E A, Galliamov, M G, Ermakov, N V, Rodina, A V, Fomin, V V, Mukhin, N A

“…To study clinicopathogenetic characteristics of cardiorenal syndrome (CRS) in non-alcoholic fatty disease of the liver (nAFDL). Insulin resistance markers,…”
Get more information

Association of obstructive sleep apnea syndrome with the signs of nonalcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome by Severova, M M, Fomin, V V, Lebedeva, M V, Sorokin, Iu D, Saginova, E A, Minakova, E G, Galliamov, M G, Mukhin, N A

“…to assess a relationship between obstructive sleep apnea syndrome (OSAS) and the signs of nonalcoholic fatty liver disease (NAFLD) in patients with metabolic…”
Get more information

Endothelial dysfunction and renal lesion in obesity by Mukhin, N A, Fomin, V V, Saginova, E A, Moiseev, S V, Kutyrina, I M, Lebedeva, M V, Minakova, E G, Gitel', E P, Samokhodskaia, L M, Domracheva, T S

“…The subjects of the study were 29 men (mean age 37.7+/-9.3 years) suffering from abdominal obesity without carbohydrate exchange disturbances or signs of…”
Get more information